Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $131,409 - $213,337
1,151 New
1,151 $206,000
Q3 2022

Nov 04, 2022

BUY
$160.42 - $256.21 $184,643 - $294,897
1,151 New
1,151 $215,000
Q2 2022

Aug 04, 2022

SELL
$140.68 - $188.02 $161,922 - $216,411
-1,151 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$161.19 - $257.96 $185,529 - $296,911
1,151 New
1,151 $216,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.32B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Redwood Financial Network Corp Portfolio

Follow Redwood Financial Network Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Financial Network Corp, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Financial Network Corp with notifications on news.